Two genetic approaches to the galactose alpha 1,3 galactose xenoantigen.
d'Apice
A J
AJ
Immunology Research Centre, St. Vincent's Hospital, Fitzroy, Victoria, Australia.
Tange
M J
MJ
Chen
G C
GC
Cowan
P J
PJ
Shinkel
T A
TA
Pearse
M J
MJ
D000818:Animals; D000910:Antibodies, Heterophile / Q000097:blood; D015478:Antigens, Heterophile / Q000276:immunology*; D002240:Carbohydrate Sequence; D004187:Disaccharides / Q000276:immunology* / Q000378:metabolism; D004730:Endothelium, Vascular / Q000201:enzymology; D005647:Fucosyltransferases / Q000096:biosynthesis / Q000235:genetics*; D005700:Galactosyltransferases / Q000235:genetics / Q000378:metabolism; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D008969:Molecular Sequence Data; D011323:Primates; D011995:Recombination, Genetic; D012799:Sialyltransferases / Q000378:metabolism; D013552:Swine; D000094663:beta-Galactoside alpha-2,3-Sialyltransferase; D000097631:Galactoside 2-alpha-L-fucosyltransferase
D000910:Antibodies, Heterophile; D015478:Antigens, Heterophile; D004187:Disaccharides; D005647:Fucosyltransferases; D005700:Galactosyltransferases; D012799:Sialyltransferases; D000094663:beta-Galactoside alpha-2,3-Sialyltransferase; D000097631:Galactoside 2-alpha-L-fucosyltransferase; C055075:galactosyl-(1-3)galactose; C038887:N-acetyllactosamine alpha-D-galactosyltransferase